[HTML][HTML] TGF-β signaling in health and disease

J Massagué, D Sheppard - Cell, 2023 - cell.com
The TGF-β regulatory system plays crucial roles in the preservation of organismal integrity.
TGF-β signaling controls metazoan embryo development, tissue homeostasis, and injury …

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

HL Ang, CD Mohan, MK Shanmugam… - Medicinal research …, 2023 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is a complex process with a primordial role in
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …

[HTML][HTML] TGF-β in developmental and fibrogenic EMTs

JH Lee, J Massagué - Seminars in cancer biology, 2022 - Elsevier
TGF-β plays a prominent role as an inducer of epithelial-mesenchymal transitions (EMTs)
during development and wound healing and in disease conditions such as fibrosis and …

Transforming growth factor-β signaling in immunity and cancer

E Batlle, J Massagué - Immunity, 2019 - cell.com
Transforming growth factor (TGF)-β is a crucial enforcer of immune homeostasis and
tolerance, inhibiting the expansion and function of many components of the immune system …

The biology and role of CD44 in cancer progression: therapeutic implications

C Chen, S Zhao, A Karnad, JW Freeman - Journal of hematology & …, 2018 - Springer
CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types
including cancer stem cells and frequently shows alternative spliced variants that are …

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1

J Su, SM Morgani, CJ David, Q Wang, EE Er… - Nature, 2020 - nature.com
Epithelial-to-mesenchymal transitions (EMTs) are phenotypic plasticity processes that confer
migratory and invasive properties to epithelial cells during development, wound-healing …

Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis

GG **esh, AS Brohl - Signal transduction and targeted therapy, 2022 - nature.com
Metastasis is a pivotal event that accelerates the prognosis of cancer patients towards
mortality. Therapies that aim to induce cell death in metastatic cells require a more detailed …

The basics of epithelial-mesenchymal transition

R Kalluri, RA Weinberg - The Journal of clinical investigation, 2009 - jci.org
The origins of the mesenchymal cells participating in tissue repair and pathological
processes, notably tissue fibrosis, tumor invasiveness, and metastasis, are poorly …

[HTML][HTML] TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

NE Bhola, JM Balko, TC Dugger, MG Kuba… - The Journal of clinical …, 2013 - jci.org
After an initial response to chemotherapy, many patients with triple-negative breast cancer
(TNBC) have recurrence of drug-resistant metastatic disease. Studies with TNBC cells …